0001437749-24-007467.txt : 20240312 0001437749-24-007467.hdr.sgml : 20240312 20240312163336 ACCESSION NUMBER: 0001437749-24-007467 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240306 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38999 FILM NUMBER: 24742653 BUSINESS ADDRESS: STREET 1: 320 SOQUEL WAY CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 320 SOQUEL WAY CITY: SUNNYVALE STATE: CA ZIP: 94085 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 8-K 1 bcda20240312c_8k.htm FORM 8-K bcda20240312c_8k.htm
false 0000925741 0000925741 2024-03-06 2024-03-06 0000925741 bcda:CommonStockParValue0001CustomMember 2024-03-06 2024-03-06 0000925741 bcda:WarrantToPurchaseCommonStockCustomMember 2024-03-06 2024-03-06
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): March 6, 2024
 
BIOCARDIA, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
  
001-38999
  
23-2753988
(State or other jurisdiction
of incorporation)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
 
320 Soquel Way
Sunnyvale, California 94085
  
(Address of principal executive offices and zip code)
  
 
Registrant’s telephone number, including area code: (650) 226-0120
 
_____________________________________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001
BCDA
The Nasdaq Capital Market
Warrant to Purchase Common Stock
BCDAW
The Nasdaq Capital Market
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter) ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
 
As previously disclosed on a Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on September 12, 2023, on September 6, 2023, BioCardia, Inc. (the “Company”) received a written notice (the “MVLS Notice”) from the Nasdaq Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last 30 consecutive business days, the Market Value of Listed Securities, as defined by Nasdaq, had been below the $35 million minimum requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). The MVLS Notice provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company would have an initial period of 180 calendar days, or until March 4, 2024 (the “MVLS Compliance Date”), to regain compliance with the MVLS Requirement.
 
On March 6, 2024, the Company received a determination letter from the Staff advising the Company that it had failed to regain compliance with the MVLS Requirement by the MVLS Compliance Date and that unless the Company requested an appeal of this determination before a Nasdaq Hearings Panel (the “Panel”) by March 13, 2024, trading of the Company’s currently listed securities would be suspended at the opening of business on March 15, 2024, and a Form 25-NSE would be filed with the SEC to remove the Company’s securities from listing and registration on the Nasdaq (the “MVLS Determination Letter”). The Company submitted the Panel hearing request with respect to the MVLS Determination Letter on March 12, 2024.
 
Additionally, as previously disclosed on a Current Report on Form 8-K filed with the SEC on September 15, 2023, on September 13, 2023, the Company received a separate written notice (the “Minimum Bid-Price Notice”) from Nasdaq, indicating that the Company was no longer in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Minimum Bid-Price Notice provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company would have an initial period of 180 calendar days, or until March 11, 2024 (the “Minimum Bid Price Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. On March 12, 2024, the Company received a determination letter from the Staff advising the Company that it had failed to regain compliance with the Minimum Bid Price Requirement by the Minimum Bid Price Compliance Date (the “Minimum Bid Price Determination Letter”). The Minimum Bid Price Determination Letter indicates that the Panel will also consider this matter in their decision regarding the Company’s continued listing on the Nasdaq Capital Market.
 
The hearing request submitted by the Company described above will stay any delisting or suspension of the Company’s securities and the filing of a Form 25-NSE pending the Panel’s decision with respect to both the MVLS Determination Letter and the Minimum Bid Price Determination Letter. While the Company will present a plan to regain compliance with respect to both the MVLS Requirement and the Minimum Bid Price Requirement before the Panel, there can be no assurance that such Panel will grant the Company’s request for continued listing or, even if it does, that the Company will otherwise be able to regain compliance with the applicable Nasdaq listing requirements.
 
If the Company’s securities are delisted from the Nasdaq Capital Market, it could be more difficult to buy or sell the Company’s securities or to obtain accurate quotations, and the price of the Company’s securities could suffer a material decline. Delisting could also impair the Company’s ability to raise capital and/or trigger defaults and penalties under outstanding agreements or securities of the Company.
 
Forward-Looking Statements
 
This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern the proposed transaction and the Company’s expectations, strategy, plans or intentions regarding it. Forward-looking statements in this Current Report on Form 8-K include, but are not limited to, the Company’s intention to present a plan to regain compliance with the MVLS Requirement and the Minimum Bid Price Requirement.
 
All forward-looking statements included in this Current Report on Form 8-K are made as of the date of this report, based on information currently available to the Company, deal with future events, and are subject to various risks and uncertainties, including the risk that the Company may continue not to meet the MLVS Requirement or the Minimum Bid Price Requirement in the future, the risk that the Company may not otherwise meet the requirements for continued listing under the Nasdaq Listing Rules, the risk that Nasdaq may not grant the Company relief from delisting, and the risk that the Company may not ultimately meet applicable Nasdaq requirements even if such relief is granted, among other risks and uncertainties, and actual results could differ materially from those anticipated in those forward-looking statements. The risks and uncertainties that may cause actual results to differ materially from the Company’s current expectations are more fully described in the Company’s Annual Report on Form 10-K filed with the SEC on March 29, 2023, as amended, any subsequently filed Quarterly Reports on Form 10-Q, and its other reports, each as filed with the SEC. Except as required by law, the Company assumes no obligation to update any such forward-looking statement after the date of this report or to conform these forward-looking statements to actual results.
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BIOCARDIA, INC.
  
   
/s/ Peter Altman, Ph.D.
  
Peter Altman, Ph.D.
  
President and Chief Executive Officer
  
   
Date: March 12, 2024
  
 
 
 
 EX-101.SCH 2 bcda-20240306.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 3 bcda-20240306_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 bcda-20240306_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key Class of Stock [Axis] Class of Stock [Domain] CommonStockParValue0001 Custom [Member] WarrantToPurchaseCommonStock Custom [Member] EX-101.PRE 5 bcda-20240306_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information
Mar. 06, 2024
Document Information [Line Items]  
Entity, Registrant Name BIOCARDIA, INC.
Document, Type 8-K
Document, Period End Date Mar. 06, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-38999
Entity, Tax Identification Number 23-2753988
Entity, Address, Address Line One 320 Soquel Way
Entity, Address, City or Town Sunnyvale
Entity, Address, State or Province CA
Entity, Address, Postal Zip Code 94085
City Area Code 650
Local Phone Number 226-0120
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000925741
CommonStockParValue0001 Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.001
Trading Symbol BCDA
Security Exchange Name NASDAQ
WarrantToPurchaseCommonStock Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrant to Purchase Common Stock
Trading Symbol BCDAW
Security Exchange Name NASDAQ
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 3 22 1 false 2 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.bcda.com/20240306/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports bcda-20240306.xsd bcda-20240306_def.xml bcda-20240306_lab.xml bcda-20240306_pre.xml bcda20240312c_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bcda20240312c_8k.htm": { "nsprefix": "bcda", "nsuri": "http://www.bcda.com/20240306", "dts": { "schema": { "local": [ "bcda-20240306.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "bcda-20240306_def.xml" ] }, "labelLink": { "local": [ "bcda-20240306_lab.xml" ] }, "presentationLink": { "local": [ "bcda-20240306_pre.xml" ] }, "inline": { "local": [ "bcda20240312c_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 30, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://www.bcda.com/20240306/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "bcda20240312c_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "bcda20240312c_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "bcda_CommonStockParValue0001CustomMember": { "xbrltype": "domainItemType", "nsuri": "http://www.bcda.com/20240306", "localname": "CommonStockParValue0001CustomMember", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "CommonStockParValue0001 Custom [Member]" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "bcda_WarrantToPurchaseCommonStockCustomMember": { "xbrltype": "domainItemType", "nsuri": "http://www.bcda.com/20240306", "localname": "WarrantToPurchaseCommonStockCustomMember", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "WarrantToPurchaseCommonStock Custom [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.bcda.com/20240306/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001437749-24-007467-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-007467-xbrl.zip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

6^0#_P]>]"Z@7[M4_T/$_T8DAGJ]WNC%0K+H'E(2EU.;O9/@#\3U2^R8#6.NXIR M@Z'S6)[:UD3U]6RQRP.'<;5+=MRZ:I6!^ MT>ZYY^I3SF+ MLH]B6-ZAH!HB3T3CXB+>>N=9*M)=W$)-LXPIL8]\S#[F6(AKE3)5%U*7/85E MK*N,HLVK4^8>%#.+T]#REMG%-)VX>Y^F;&8V+G[4XFQ\B("S]O: MWC>1VYN,2EC).Y(X3L<5,-,7)]OAH)B>Z;R#HYH(.Z7*4XF)/5?:<<&CQ%WP M\G(RBB4E;H"7TY5?:;&0]:&BLDZHRUBHO*JH2E-AQT+2=44E616#+/3]45%] MN44D"VU_5EN;J?QDH>RFVLHR:U8V>W7Q:>:[]&74NFS452\5,5?,;/14+Q?) MKKG9:*I>'F)1L+,15KU,)*_@9Z.J>IF';:'01EWUDI#32HLV&JN7B&07)VTT M52\!R:APV@BJ7MZ17Q^U>9FN:KYA45:UD5>]A".C-FLCJ'H9AT5A]^!&ULS9QK;]LV%(:_#]A_X+PO&U!%=MP62-"T M"-RT,)HT1NVNPXJAH"7:%BKI&!2=V/]^).6;;%(WF]2^-+9T=-[C]SP2J5O? MO%M&(7HB- D@OFEU+MHM1&(/_"">WK2^#IW;8:_?;Z&$X=C'(<3DIA5#Z]W; M7W]Y\YOC?"0QH9@1'XU7:#1;Q#ZA[R$B: "4X1 YJ.MV+MW+]N5+]/KZ5?>Z M_0H-'AQ';!X&\<]K\<\8)P3Q,N)$?KUIS1B;7[ON\_/SQ7),PPN@4YZBW74W MT:UUN%CKL^T&^\&OW'3E-O0H]7-7QG:NKJYJTDE ,!$ /?V%^"B?<=ZJ4!$J>;M,D@4?=5$5&SM01;3W95R:--CH6BWPSK3H(0;1OK\'KQ% M1&+6CR= (SDOXT<8TF>$(511ND8\>0Y1.ROKDF!2&&K\R^0 M4&NDUQFGH,@"HSW=GAV^Y[/JG.8JXVIV.9/+7KM363Y;\)$0;J3S:ANAM#]& M6$AG*%_(-$@8Q3'[C",5"GEAMU M8!*D]PD*.E\07PL#34Y;3'!YE-5OCI B>Z&R;P;9N?5];F^R_B-.B#M:;G)B M:S&CR&>+E[7F]@.25S >XR8&F3Q;H9)?YCGI\8^/= 3/^NO6VLA3&-EELTZ( MD!93$2'>'!T*.U5LZ'PR3X::YIS]YP:PPTNMO-&",Q#V(HD6\/L51W2;-C:O8=64NTZU? MBZ*LJM7VYWL(IN['A[TBC51E+< M*A@E3(5J;MD I9\D"T(KX:+=Y#1HCM):1R>MX']#D-YG-4<%!IH9;8BWX /= MJG,Y'@5,^92-+J3J2'.0QC0=4@3!!'4N_QC_B3;R=L<:G750QA,C#1]1+-XM M&:ZB,:AF%LKU%5N=R6&\SZD82M6LME?M%12:8'1/OEMZ,^X/T3PYD1=6 M3V5\]KC61!M1^P].Y#H(9:TQ>,'P+B)TRM'[2.&9S?@(,\?Q2GO%,#>ZUB5# M949;UPPWXBA51VOY!BX9YAL+%1TSPLLMGW;X8NKQ(<13!2'*]169R.0P3<%6 M# DUJTU7>P6%)A@\$/2X(,5AGT\HEY^(_A"@B:NU\Q_DLK7;KV61U$5R!(V]$"?)XV3(P/NI M>!>G='P%4@IS&K^U(/3$>8%4M/VF3GE+H;)7ENC9+T+Y:EYQ8 U>CI/9!L7V M:WLE;(3R_I2#8^SY6'3\9;O;3E\@%4M^B*L4XB%-GGN Z5\X7)!VN]WI+1(& MT0-1W)NJNED%(LJF-LZ'N@24UH"^IU78XZ6RY5#7RY-8^H:I>)1\! /NZPPG M9$^^"*BJVU:EJFQ^X_?(#?[W7X*"/BQ$P55/("Q#ZVCT^N[9M[P_N/JX@Y+R DY7'';=3JK@-Q MP$,:SSKNMY'7'?7Z?=>1BL0A83R&CAMS]^.'WW][_X?G?888!%$0.I.U,YXG M<0CBED?@#+E0A#F>T_(;3;]9;[YSKMM7K7;]RAG>>YYNSFC\W-8?$R+!01JQ M3"\[[ERI1=OWE\ME;341K,;%#+NHM_P=VMW"=6VH]@T.P5?^IG(//>IZV4JQ MC9N;&S^MW4,ES0)BIPW_W_O!*)A#1#P::TT"S472MDP+!SP@*A6R< J.$:&O MO!W,TT5>H^FU&K65#-V]<((S>(2IH[^_/?9?C3@)0E(+>)3J7F_5KWV-\I&O M@@ABY84\2-(?>%,]_*9JC?.9W)%:+]!N M)(T6#%Q_/X>% (F-4N@ "[9H3;:4^6QHP$H!VNF!EHP'KV:LAY8[>Y(0U&;\ MQ0^!ZO%;^H>6HY5*@1=/=^F :/:$[H=B9 *LXYJJ-TR8-A+:*!1>I MZ8ST!M;C2:S$NL=#,U&K5J7R_D09?$VB"0@CR6-(J8S&9-4/]5X_I9M#MX!> M ;Y4KMTPQ*-.;K_TCM$P\LS!GH-C#W\^B#%?FH\R(_(<_%+K?Q!#P5_HQOO* M)6F GX/ID*.#POZCB]REG0+M19#D"N;B2N(TXHP%5^&1VCT8M*&$9Q,R@DE@-!6@5\*$Q M]<7'VK<6#]-IYMTL!I^'95_*!,1)7(U-RKK;$"1H9.M&W4.&$W!JLY\D^)T(_4 XYL-$X)XA MX6#H(I:GMC51/8R+=47@<(%G3L>MNP[6X,DC(!QLAC4&$=, 6V M<0EAQU4BV>^!1 1'T;;7'6T1_H(('6 +YI2%N]93P:/\L!(O"H%A]\43;_R: M$[=?W]Q^95D)TJR (&];UU;RM*HBS]LVE)U&E[N=% :#N44T^Y*W%EL13G0Q M+"WC%]U>3K$,^T"]E9EL)=A&SBKBE.:]&V.E0$;_4XG6,@XR#?R0)=OS\85^C/_1?7K#D?U!+ M P04 " PA&Q8>6T?XL45 $B4?26S'2:9'2!R[V'L7(+3]WYN)QZY$J&3@OWYEUZU73/A. MX$K_\O6KW?/!P<&K_^[\M#V.H!MT]=7KRCB*IOU&X_KZNG[=J@?A9.*O94PJE?!E<- M:H(QS59^7KD4A59#^BKBOB/2_LHM6QGTM1M_'1V>.V,QX4EG>1/5 '1A0(** M]#WIB[_>G!TVHI#[:A2$$QX!=6$NNU.S-FLM.P4*73\N)RBVYD"6K^8V>,U: MLYM2,/#]>%(^CQN%C6@V%0WH5(->(I1.,BY6-6S*B#_B:DBCDI8"[>,H%)=+ M:=]K0'NVK&7][%9N:3E$PL!;@@BU(")6S;)S5%;1-"P7&VPI8+[ CZ+08/.0 MJU1HI K:37MCE9CI'LD (/(<)8B,+HL[UW;R4L_%+5G6"28_'=&'Q3:C!NP<45LIQAT%"4-%6[Y'Q: M*@[84.CL!+$?A;/RF4UC84"X1&Q"%!I[ MV,$>NM%N.G]O?JR#M=]NZ+:?_@7=_EVKL7?"%R&/A,N&,W:A!6H/!(J=!F'$ M/59CK8;=)""LV^^T^I;-3H]8K08>9B(BSA"EFO@4RZO7E4'@1\*/:A>@$!7F MZ*?7E4C<1 UR-8V=[89&! M:[,! BY=P LNGDO9CDX;:NR8\&?7K.ST;87@/U$;_)+ V\N4&:%@F JQI"859Z5D$_S".9 B1IX7*F3T7D4 M.!]W;Z3Z>Q!,)H%/SZ<\_)-[L8#5VX] 1D,+<8EXF6<7X-U,/>G(Z$A,A@#$ M!3WU*32M&(O>7[J8"MFH_I(E#6(5!1,][7:C%%I&U0RM%\7M#SR$"#&Z"$Y! MD<80Q^1H]2VS?-6Z7AC??TJ,8V8,&WFOTP#WA.*1\U)Y]_=JSO&]VLJ\)3E+ M>KSBH01Z@MF'5,+;FO#P4OI];*[L_/JSW;6VG@N<.3!W@8*$K'%/7OI]!]@K MPB+<[>'.'\<'%_M[[/QB]V+_?+LQW'D2+,[W!W^<'5P<[)^SW>,]MO_7X+?= MXW?[;'!R='1P?GYP#+-EO M3\Z.V/V"K;W B=&DZ" VB;'L39IOL_9>TZP88GTC='RX^(!@G^T?7["S_=.3 MLXNGD6)P%2J&[BP*V+EPL&#"[!8[.6-V9\U=9\&(16.!37$H(PG0]R'5XOZE M8+M.A,UVK]5^N6Q"AX2K/!-3R-W86O(L.#@DH2(FKF 4"ZE9N.O].RF&+DZA M$D1]%YTZ=!J[?#:#:85?ICBGY KWM8?,92E=DJ0C#@Z?=:L, 93KTB,S*.)# M3[!A$((_?EVQ('$5GF?RRO193;F3/-^?F]?2C<;]=KN^:;5Z3;O3W>PV-SJ_ M&+1JGAA%?" 7,^GF%^0/9[)BZEPG)I M= PMF5BUVB16;PY.!KMG>P>[579P/*BO$"Q<:2/".@G^G\A90M6O2;4'ZO?: M_@T'.X:$0;4.4X(PKIB:"@>C=I=)G\E(,;!\H.7A^M)50^1I9*I!&O B5:[; MJW?LC=Y&:[/3;4*F\_0JU[+JS<>7G7M:>MPJP7PH$M,PN$*)*YIZK9('OA.$ MX$QH[X(ROH$NR0X"-Z>A[0YIZ)[P^#7XC+NIYEUUL?-+3KH6A[Y,3LTSXJWT M! R Q#BC>L8-4XD'_$)2_@R9@64T MJ=13T1X-$=-:\%V1_>#LG.U/IEXPPY+E$Q"^:(?8<5#_S@._5J\.1KO5[5IV MR]JP>T\?^/4Z]>ZWX==V73<42IG_'4I?V)E/V] ^K=6TV'GP*18>^\!GI7YM M&#;T8H>?@\4 _GH27@37?@Z'GJZWQKX_N^)>:4A9O6]UXVXQK\&*G-Y)> H] M)9V"2%#;M'6]##@"<_N2E^%VSXID ?)I #AZ_R>GQ2![LT5P>VUKLW-+A?(A M%EF+;M$F/S!,>1H]6#/DP\QY&@+/Y)1[3-P()X[D%2;48#P!)O==]C\Y!9:X MXG-'[]>?-IKVQ!>\5BX0GIN/ %\RG6*&*$9L7HQ-@ MD"%RHGZ?K=U/3=!2[,+HHF+T='VHV['*U&+]GJIX& ##3Q'U^5B_I\N;S6:W M9MG-4F O>Y?@[_O\^8;)4( R& OG(VT[\"FX#; LF P-@QLV%%YPS:3>DW@+ M0]EF[3T;T;D\)A5(?"1\5[BXFZ'D)/8B[HL@5MZ,*0CBU&A&(\V 8 ATU[&= MV>;(E?_HT!98KEG2-@H\ ([CT)5)3 =4_YNIJVL+RFS+^F6+D=!)'\/;/K.F M-XLQVA)S#'2=)EXFL]G)W)N$\+P+,JMA= 8M)^X,@\:[GTJK,GI=90K4?F3& MY8ZW/:P<-PP";\B!L;#RF[Q-^A#*"&0)4[_8-QF RN^[=)$UO8UV>^M^!2!# MK#0T?B)BF?4!E?(+9-/<=N!9#)+6;G:,*LQM ^+NWYJ]P09OSU@3,D3H^+*R MHQ\:M+MGBV,2L;E%7[#:OV@.+K#FY5=[J;^RV M6VNN#=?OID6Z[P\]^J%'J80=*!6+<(DV];XW;6J)6GO-N9LVF;[/4YN^4JJ9 M"VAU[B="R!ZG98?BR"J97!!HUW_\\CN9A"]8<4^L 9@5@WZ-.O09%>'3ET[@ MX9<_0X]#6J[_&UX.UZPJPW_6M]B\[3%5.Y8 Z-8[CU^9,;C728(O)D*=3(1(TQ=D*&G5:O_D(G:[1W_ MUU?YY%+;Z9G='))>YYSZAE79T3,PFJ+*ICQD5S@+^X]5AXGNY^L_Z^CGD\CR MUR:^L1_:?.0I;U=VW@SV=C^'OE_&S'X3.G(!@#*_'@"0-9P1DNV6487$=C+)E,<5>7*^:*D?3UQQUZ MK\OJE'SOEGWFUDKK);C@C2W:]DK&2/HZ9(I?A^"Y75U^:0YKS3M^0C<_-U9D MLN'YV;]H]4P?@]HW1'I'-!IH$N7E_M;=SI<@7:,5\H*G:4J%3RZ<' #3PX0G M'+S_Q0_(^\;@>+$7\,F<3\ KJB05EO1'[L@Q@N7-$/BU!- HICZL!UI"<245 MC .!Y;Z#NT_&N3RT%7Z9(*[K(+56N-I!2LO@G66\O8)>$F5F=>5 MTW=OWI?7P/,5+UUC+92\\!7>VE"8Z_B/HW2R?$76.!Z6 [" U#BMJ9_NOMNO MO3G;WWU?VWU[L7_69]R[YC.5N$Y]XTUAMBTV%AJM)A9.3'$D"9'8$#PK"%;L MN[5B$]WW4EC";WMGI4O01>7E"W@N"OFYI=GMX'K6JELV.PX@VJ&"S9[P M0-'H^$[(WG+IQ:$@*3?G>SC#"Y.D'X,6')J>9(RA^[E1E"UV05?$@<^ &4VO M^LLY2?9/#"L:S?* \QM)K2YALHOV NR*/A_E2N5X =H8,!5 1+I_*TJ^>X9W M^>-6T(LLU)Q?PW.>J6')OII@:]@/SRHVK:WS_0']S=Y:QUG/!3@UNO#$;M+G MRZUJ\74W>?M&!@/@G>15=N []<*DQF.E$X?"$?(*L.3LVAQT\;4$Y4<=_7EX M;B0K'3D*@PDM2X=YJ0C]'N/AXW2G!4SN:%1<%[[)5C9B%]DD%(*:R) ='@[8 MFAFDV]-1QL4@O&C,HRHY!80!-B%B+0M]O4H.UPYC!=&+@C &+%*5NAD(5!E( M)!N(D'&HF@][P(]I^%5P6? (H; Y8(=S_:?5@:3"\Y!_$^G+23P!LGZ*9:BW MGK2_2C0MU4D_3[QB3&PVH>8(2[K9Z72LM>'Z6G-]D4%G&="$4'4B;HY]F>/3 M=(.(#OUCZ.)M>EI42\%NVM::L[[66E\;K&L2&DEBUT'LN4 7(#0$!;#^B(Y\ M:%^-(=LF<(-[ NV)X0 0!!TR+=<9L[;^&G]Q00C"DX09?LR?+*J*5@S"""Y] M'0C(#/DH66Z.&/7OR5:=^*QPQT&163EU=P7X=Y!7?:S3$Z#[8:;4I*2,NWA\ MDY0LFP,%A\F(5&'$R<3=CQ^H3^G[.1Z3920(L>^ASA:Q_Q0+4E20-#Z="A"T M).@O+FS:2I>0H2UMF=!#92@VN' MTNS4CL_WLRGGG!&;$TN$,)*@7!_Q+9BF!:W<*U#ZD 2G M:&\2?JEX.$&?XM)\FO1CS8F$EWH!H< +!"@&3P6C#$R.1-H'MK\KW=YU7:X,)(Q_?"/=VFF(K6511>)L MY[Q\T>W \OV >0%$4"%;8GD2=SR4+GYVXXC/=,Q$="5H*( J$M]-%_TT=G: MF5[[]A$S/T7O;=IG[7ECK0WWY*J+5V1)+0G2-?YB;O MI6C?E5E';LV[QV 1)UHSIUES.KX,.E?MJ9T5( MH..N[(N?T5S<@>%+PMLT9*))4@&8=^7#(!\ EDI? O5NPEIG'\;XB7_!@.'Z MP0\J5"[.IAZ8L>7ZN12[O(HN1ZJ@R#K$3.E!E@=>.!S#3_1-7*DX)-BD6BH& M.Y73K4N]XUC"ED0(ECBHL$IWJ6%!%>R2&PA*:N?](X*@.S&NI1*($1V^6VVZ M(*;VP!I@1Z.6"="W*XYP'2M=UAVGJN*S,JPLOU52,=>!SNP70>*D8CP*# M)J5?;X!^XZ\JU',%1=V5G(.$^618.CJ$SZHF$$U>H2N:?Z?&:$+FWXH;],YJ M_C4Z]867( <2KU& T'6^R2F;6W_QO- W H$!PSP/,0S^*<.$MI#!;Y9!'8)Y M!%(OO =/+B=E R!JP9NJ%M\'^,,58'J3]V#L,Q@BF5$FCSE6N93=S)O)77 M/$N<#A61Q.6L2I$8@2+"Z\V +$60T4II)@5;K:OZS@91!:<9D0_&'60/UDGU MIJ!:BFR*"ZK'G:/&AT>)+]<5E96G(&I984,,P]R[,!?Y.>&N0,-B#*5K[A.F MH?H68> ]-Q4OZ:<_8Y6KR/(K2-B3N#*LJN#Z$##M!M,1X'NYC&\LEAAXD0NM/1X9]%X3)Z MO3H#,5Y(+Z!Z"VP$F:4#*>1\7+\DW\B^B"JI+:EYN*9/ G(AR4'W),5(!\II MNII%JZM7 &$BV5+@+2UA,6$I+"A)D\A'&< @/824< 'H)$#W329R*7=)(IPH M!H$!@T&!JHY_,72'@4F@##B9Z!]L)\O2%Y[ ! M25J*RM+]BH+=UOJ&Z<@HQL%9D<'(V/PDN[Z/&,QIKFTM+2_K*EVSE]20LZBF MRLQ6@<*LE]163_%[3%<(P[,&H_)P?M=\P:N&#?MTGZK^3@6F7\2CCA&6F-*% MQ49,J+SB\>MBV1 3=S27?I"_^01/)TU=O4ZE<,/W()MP3(2A"] >!,94?HVYMXH*2630S<=L&09^^A! M<#H>@Y\*8;'NLPE@)73,:/C-Z/)+J/C5K<%>_/W=[ MYQ>U+,!?R"#>7IS-O1N/:F%PO?@2?3_3*4=I)#X7E\-?#)GQ]X5W_A]02P$" M% ,4 " PA&Q8/'9)&:H# ! #P $0 @ $ 8F-D M82TR,#(T,#,P-BYX&UL4$L! A0#% M @ ,(1L6([D"_3'!@ 5D4 !4 ( !C0D &)C9&$M,C R M-# S,#9?;&%B+GAM;%!+ 0(4 Q0 ( #"$;%CD_$ 4 )8T 5 M " 8<0 !B8V1A+3(P,C0P,S V7W!R92YX;6Q02P$"% ,4 M" PA&Q8>6T?XL45 XML 16 bcda20240312c_8k_htm.xml IDEA: XBRL DOCUMENT 0000925741 2024-03-06 2024-03-06 0000925741 bcda:CommonStockParValue0001CustomMember 2024-03-06 2024-03-06 0000925741 bcda:WarrantToPurchaseCommonStockCustomMember 2024-03-06 2024-03-06 false 0000925741 8-K 2024-03-06 BIOCARDIA, INC. DE 001-38999 23-2753988 320 Soquel Way Sunnyvale CA 94085 650 226-0120 false false false false Common Stock, par value $0.001 BCDA NASDAQ Warrant to Purchase Common Stock BCDAW NASDAQ false